tibljТуберкулез и болезни легкихTuberculosis and Lung Diseases2075-12302542-1506Медицинские знания и технологии10.21292/2075-1230-2016-94-10-55-61tiblj-946Research ArticleЛЕКЦИИLECTURESПРАВОВЫЕ ОСНОВЫ ПРОВЕДЕНИЯ BCG-ТЕРАПИИ ДЛЯ ЛЕЧЕНИЯ РАКА МОЧЕВОГО ПУЗЫРЯ В УСЛОВИЯХ МУНИЦИПАЛЬНЫХ ПОЛИКЛИНИКLEGAL BASIC OF BCG-THERAPY FOR BLADDER CANCER IN MUNICIPAL POLYCLINICSЗоринаМ. М.ZorinaM. M.

кандидат медицинских наук, заведующая эпидемиологическим отделом, врач-эпидемиолог,

630040, г. Новосибирск, ул. Охотская, д. 81а

Candidate of Medical Sciences, Head of Epidemiology Department, Epidemiologist,

81a, Okhotskaya St., Novosibirsk, 630040

urotub@yandex.ruКульчавеняЕ. В.KulchavenyaE. V.

доктор медицинских наук, профессор, главный научный сотрудник кафедры туберкулеза НГМУ,

630040, г. Новосибирск, ул. Охотская, д. 81а

Doctor of Medical Sciences, Professor, Head Researcher of Tuberculosis Department of Novosibirsk State Medical University,

81a, Okhotskaya St., Novosibirsk, 630040

urotub@yandex.ruХолтобинД. П.KholtobinD. P.

кандидат медицинских наук, врач-уролог урогенитальной клиники,

630040, г. Новосибирск, ул. Охотская, д. 81а

Candidate of Medical Sciences, Urologist of Urological Clinic,

81a, Okhotskaya St., Novosibirsk, 630040

urotub@yandex.ruФГБУ «Новосибирский НИИ туберкулеза» Минздрава РоссииРоссияNovosibirsk Tuberculosis Research InstituteRussian FederationФГБУ «Новосибирский НИИ туберкулеза» Минздрава России; ГБОУ ВПО «Новосибирский государственный медицинский университет» Минздрава РоссииРоссияNovosibirsk Tuberculosis Research Institute; Novosibirsk State Medical UniversityRussian Federation20160110201694105561Copyright © Зорина М.М., Кульчавеня Е.В., Холтобин Д.П., 20162016Зорина М.М., Кульчавеня Е.В., Холтобин Д.П.Zorina M.M., Kulchavenya E.V., Kholtobin D.P.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.tibl-journal.com/jour/article/view/946

Представлены краткие данные литературы по истории создания вакцины BCG (Bacille bilie' Calmette-Gue'rin), результаты метаанализов по оценке эффективности BCG-терапии при раке мочевого пузыря Та-Т1. Приведены описания клинических случаев возникновения побочных реакций и осложнений данной методики по данным литературы и результатам собственных наблюдений. Основной причиной низкого уровня применения BCG-терапии в России является недостаточная осведомленность медицинских работников правовых норм проведения данной методики. Представлены перечень действующих нормативных документов, регулирующих обеспечение эпидемиологической безопасности при проведении BCG-терапии, и в соответствии с ними технология проведения данного метода в условиях муниципальных поликлиник.

The article presents brief data from the literature about the history of BCG vaccine development (Bacille bilie' Calmette-Gue'rin), results of meta-analyses aimed at the evaluation of BCG-therapy efficiency in Ta-T1 bladder cancer. Below one can read descriptions of clinical cases when side effects and complications of this method developed according to the literature data and results of authors' personal observations. The main reason of low level of BCG-therapy use in Russia is low awareness of medical workers about the legal grounds for application of this method. The article gives the list of acting legal acts regulating provision of epidemiological safety when applying BCG-therapy and describes the technique for using this method in municipal polyclinics in compliance with the above legal acts.

вакцина BCGрак мочевого пузыряэпидемиологическая безопасностьBCG-терапияBCG-therapyBCG vaccinebladder cancerepidemiological safetyReferencesКульчавеня Е. В., Краснов В. А., Скорняков С. Н. и др. Современные тенденции эпидемической ситуации по внеторакальному туберкулезу // Туб. и болезни легких. - 2013. - № 12. - С. 34-38.Kulchavenya E.V., Krasnov V.А., Skornyakov S.N. et al. Current tendencies of epidemiological situation of extrapulmonary tuberculosis. Tub. i Bolezni Legkikh, 2013, no. 12, pp. 34-38. (In Russ.)Холтобин Д. П., Кульчавеня Е. В., Брижатюк Е. В. и др. Два наблюдения сморщивания мочевого пузыря под воздействием микобактерий туберкулеза разного вида // Урология. - 2012 - № 3. - С. 44-47.Kholtobin D.P., Kulchavenya E.V., Brizhatyuk E.V. et al. Two clinical cases of urinary bladder contraction under action of tuberculous mycobacteria of various types. Urologiya, 2012, no. 3, pp. 44-47. (In Russ.)Aust T. R., Massey J. A. Tubercular prostatic abscess as a complication of intravesical bacillus Calmette-Guérin immunotherapy // Int. J. Urol. - 2005. - Vol. 12, № 10. - Р. 920-921.Aust T.R., Massey J.A. Tubercular prostatic abscess as a complication of intravesical bacillus Calmette-Guérin immunotherapy. Int. J. Urol., 2005, vol. 12, no. 10, pp. 920-921.Bohle A., Jocham D., Bock P. R. Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity // J. Urol. - 2003. - Vol. 169, № 1. - Р. 90-95. http://www.ncbi.nlm.nih.gov/pubmed/12478111.Bohle A., Jocham D., Bock P.R. Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity. J. Urol., 2003, vol. 169, no. 1, pp. 90-95. http://www.ncbi.nlm.nih.gov/pubmed/12478111.Bohle A., Bock P. R. Intravesical bacillus Calmette-Guerin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression // Urology. - 2004. - Vol. 63, № 4. - Р. 682-687.Bohle A., Bock P.R. Intravesical bacillus Calmette-Guerin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression. Urology, 2004, vol. 63, no. 4, pp. 682-687.Bulbul M. A., Hijaz A., Beaini M. et al. Tuberculous epididymo-orchitis following intravesical BCG for superficial bladder cancer // J. Med. Liban. - 2002. - Vol. 50, № 1-2. - Р. 67-69.Bulbul M.A., Hijaz A., Beaini M. et al. Tuberculous epididymo-orchitis following intravesical BCG for superficial bladder cancer. J. Med. Liban., 2002, vol. 50, no. 1-2, pp. 67-69.Foster D. R. Miliary tuberculosis following intravesical BCG treatment // Br. J. Radiol. - 1997. - Vol. 70, № 832. - Р. 429.Foster D.R. Miliary tuberculosis following intravesical BCG treatment. Br. J. Radiol., 1997, vol. 70, no. 832, pp. 429,Griggs H., Cammarata S. K. // Chest. - 1998. - Vol. 114, № 2. - Р. 621-623.Griggs H., Cammarata S.K. http://www.ncbi.nlm.nih.gov/pubmed/9726755. Chest, 1998, vol. 114, no. 2, pp. 621-623.Gupta R. C., Lavengood R. Jr., Smith J. P. Miliary tuberculosis due to intravesical bacillus Calmette-Guerin therapy // Chest. - 1988. - Vol. 94, № 6. - Р. 1296-1298.Gupta R.C., Lavengood R.Jr., Smith J. P. Miliary tuberculosis due to intravesical bacillus Calmette-Guerin therapy. Chest, 1988, vol. 94, no. 6, pp. 1296-1298.Hughes R. A., Allard S. A., Maini R. N. Arthritis associated with adjuvant mycobacterial treatment for carcinoma of the bladder // Ann. Rheum. Dis. - 1989. - Vol. 48, № 5. - Р. 432-434.Hughes R.A., Allard S.A., Maini R.N. Arthritis associated with adjuvant mycobacterial treatment for carcinoma of the bladder. Ann. Rheum. Dis., 1989, vol. 48, no. 5, pp. 432-434.Kesten S., Title L., Mullen B., Grossman R. Pulmonary disease following intravesical BCG treatment // Thorax. - 1990. - Vol. 45, № 9. - Р. 709-710.Kesten S., Title L., Mullen B., Grossman R. Pulmonary disease following intravesical BCG treatment. Thorax, 1990, vol. 45, no. 9, pp. 709-710.Kulchavenya E., Kholtobin D., Filimonov P. (2012) Natural and Iatrogenic Bladder Tuberculosis: Two Cases. Mycobac Dis 2:110. doi:10.4172/2161-1068.1000110.Kulchavenya E., Kholtobin D., Filimonov P. (2012) Natural and Iatrogenic Bladder Tuberculosis: Two Cases. Mycobac Dis 2:110. doi:10.4172/2161-1068.1000110.Lamm D. L. Complications of bacillus Calmette-Guérin immunotherapy // Urol. Clin. North. Am. - 1992. - Vol. 19, № 3. - Р. 565-572.Lamm D.L. Complications of bacillus Calmette-Guérin immunotherapy. Urol. Clin. North. Am., 1992, vol. 19, no. 3, pp. 565-572.caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation // Gut. - 1996. - Vol. 38, № 4. - Р. 616-618.Leebeek F.W., Ouwendijk R.J., Kolk A.H. et al. Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation. Gut., 1996, vol. 38, no. 4, pp. 616-618.LeMense G. P., Strange C. Granulomatous pneumonitis following intravesical BCG. What therapy is needed? // Chest. - 1994. - Vol. 106, № 5. - Р. 1624-1626.LeMense G.P., Strange C. Granulomatous pneumonitis following intravesical BCG. What therapy is needed? Chest, 1994, vol. 106, no. 5, pp. 1624-1626.Morales A., Eidinger D., Bruce A. W. Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors // J. Urol. - 1976. - Vol. 116, № 2. - Р. 180-183.Morales A., Eidinger D., Bruce A.W. Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J. Urol., 1976, vol. 116, no. 2, pp. 180-183.Muttarak M., Lojanapiwat B., Chaiwun B., Wudhikarn S. Preoperative diagnosis of bilateral tuberculous epididymo-orchitis following intravesical Bacillus Calmette-Guerin therapy for superficial bladder carcinoma // Australas Radiol. - 2002. - Vol. 46, № 2. - Р. 183-185.Muttarak M., Lojanapiwat B., Chaiwun B., Wudhikarn S. Preoperative diagnosis of bilateral tuberculous epididymo-orchitis following intravesical Bacillus Calmette-Guerin therapy for superficial bladder carcinoma. Australas Radiol., 2002, vol. 46, no. 2, pp. 183-185.Okadome A., Takeuchi F., Ishii T., Hiratsuka Y. Tuberculous epididymitis following intravesical Bacillus Calmette-Guérin therapy // Nippon Hinyokika Gakkai Zasshi. - 2002. - Vol. 93, № 4. - Р. 580-582.Okadome A., Takeuchi F., Ishii T., Hiratsuka Y. Tuberculous epididymitis following intravesical Bacillus Calmette-Guérin therapy. Nippon Hinyokika Gakkai Zasshi, 2002, vol. 93, no. 4, pp. 580-582.Palayew M., Briedis D., Libman M. et al. Disseminated infection after intravesical BCG immunotherapy. Detection of organisms in pulmonary tissue // Chest. - 1993. - Vol. 104, № 1. - Р. 307-309.Palayew M., Briedis D., Libman M. et al. Disseminated infection after intravesical BCG immunotherapy. Detection of organisms in pulmonary tissue. Chest, 1993, vol. 104, no. 1, pp. 307-309.Rozenblit A., Wasserman E., Marin M. L. et al. Infected aortic aneurysm and vertebral osteomyelitis after intravesical bacillus Calmette-Guérin therapy // AJR. Am. J. Roentgenol. - 1996. - Vol. 167, № 3. - Р. 711-713.Rozenblit A., Wasserman E., Marin M. L. et al. Infected aortic aneurysm and vertebral osteomyelitis after intravesical bacillus Calmette-Guérin therapy. AJR. Am. J. Roentgenol., 1996, vol. 167, no. 3, pp. 711-713.Sharma V. K., Sethy P. K., Dogra P. N. et al. Primary tuberculosis of glans penis after intravesical Bacillus Calmette Guerin immunotherapy // Indian J. Dermatol. Venereol. Leprol. - 2011. - Vol. 77, № 1. - Р. 47-50.Sharma V.K., Sethy P.K., Dogra P.N. et al. Primary tuberculosis of glans penis after intravesical Bacillus Calmette Guerin immunotherapy. Indian J. Dermatol. Venereol. Leprol., 2011, vol. 77, no. 1, pp. 47-50.Shelley M. D., Kynaston H., Court J. et al. A systematic review of intravesical bacillus Calmette-Guerin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer // BJU Int. - 2001. - Vol. 88, № 3. - Р. 209-216. http://www.ncbi.nlm.nih.gov/pubmed/11488731.Shelley M.D., Kynaston H., Court J. et al. A systematic review of intravesical bacillus Calmette-Guerin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer. BJU Int., 2001, vol. 88, no. 3, pp. 209-216. http://www.ncbi.nlm.nih.gov/pubmed/11488731.Shigehara K., Kobori Y., Amano T., Takemae K. Bilateral tuberculous epididymitis after intravesical Bacillus Calmette-Guerin therapy // Hinyokika Kiyo. - 2005 - Vol. 51, № 12. - Р. 839-842.Shigehara K., Kobori Y., Amano T., Takemae K. Bilateral tuberculous epididymitis after intravesical Bacillus Calmette-Guerin therapy. Hinyokika Kiyo, 2005, vol. 51, no. 12, pp. 839-842.Sylvester R. J., van der Meijden A. P., Lamm D. L. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials // J. Urol. - 2002. - Vol. 168, № 5. - Р. 1964-1970. http://www.ncbi.nlm.nih.gov/pubmed/12394686Sylvester R.J., van der Meijden A.P., Lamm D.L. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J. Urol., 2002, vol. 168, no. 5, pp. 1964-1970. http://www.ncbi.nlm.nih.gov/pubmed/12394686

The authors declare that there are no conflicts of interest present.